FDG-PET/CT (fluorodeoxyglucose–positron emission tomography/computed tomography) is effective to assess for occult neck nodal disease. We report risks and patterns of nodal disease based on primary site and nodal level from data on the dissected cN0 per the results from ACRIN 6685.
Study Design
Prospective nonrandomized enrollment included participants with first-time head and neck squamous cell carcinoma and at least 1 cN0 neck side to be dissected.
Setting
Twenty-four ACRIN-certified centers internationally (American College of Radiology Imaging Network).
Methods
A total of 287 participants were enrolled. Preoperative FDG-PET/CT findings were centrally reviewed and compared with pathology. Incidence, relative risk, pattern of lymph node involvement, and impact upon neck dissection were reported.
Results
An overall 983 nodal levels were dissected (n = 261 necks, n = 203 participants). The highest percentages of ipsilateral positive nodes by primary location and nodal level were oral cavity (level I, 17/110, 15.5%), pharynx (level II, 6/30, 20.0%), and larynx (level VI, 1/3, 33.3%).
Conclusion
Levels at greatest risk for nodal disease in cN0 in terms of ipsilateral neck dissection are level I (oral cavity), II (pharynx), and VI (larynx). These data should be considered when treating patients presenting with cN0. This is the first study to comprehensively report the incidence, location, and risk of metastases in cN0 in the FDG-PET/CT era.
Abu-GhanemSYehudaMCarmelNN, et al. Elective neck dissection vs observation in early-stage squamous cell carcinoma of the oral tongue with no clinically apparent lymph node metastasis in the neck: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2016;142(9):857-865.
2.
FurukawaMDillonJKFutranNDAnzaiY. The prevalence of lymph node metastases in clinically CN0 necks with oral cavity squamous cell carcinoma: is CT good enough for nodal staging?Acta Radiol. 2014;55(5):570-578.
3.
HirotaKWakisakaNSawada-KitamuraS, et al. Lymphangiogenesis in regional lymph nodes predicts nodal recurrence in pathological CN0 squamous cell carcinoma of the tongue. Histopathology. 2012;61(6):1065-1071. doi:10.1111/j.1365-2559.2012.04341.x
4.
LimYCKooBSLeeJSLimJYChoiEC. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the CN0 neck. Laryngoscope. 2006;116(7):1148-1152.
5.
ShahJP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990;160(4):405-409. doi:10.1016/s0002-9610(05)80554-9
6.
ShahJPCandelaFCPoddarAK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer. 1990;66(1):109-113. doi:10.1002/1097-0142(19900701)66:1<109::aid-cncr2820660120>3.0.co;2-a
7.
CandelaFCKothariKShahJP. Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head Neck. 1990;12(3):197-203. doi:10.1002/hed.2880120302
8.
CandelaFCShahJJaquesDPShahJP. Patterns of cervical node metastases from squamous carcinoma of the larynx. Arch Otolaryngol Head Neck Surg. 1990;116(4):432-435. doi:10.1001/archotol.1990.01870040054013
9.
ByersRMEl-NaggarAKLeeYY, et al. Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue?. Head Neck. 1998;20(2):138-144. doi:10.1002/(sici)1097-0347(199803)20:2<138::aid-hed7>3.0.co;2-3
10.
ByersRM. Modified neck dissection: a study of 967 cases from 1970 to 1980. Am J Surg. 1985;150(4):414-421. doi:10.1016/0002-9610(85)90146-1
11.
LindbergR. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1972;29(6):1446-1449. doi:10.1002/1097-0142(197206)29:6<1446::aid-cncr2820290604>3.0.co;2-c
12.
LoweVJDuanFSubramaniamRM, et al. Multicenter trial of [(18)f]fluorodeoxyglucose positron emission tomography/computed tomography staging of head and neck cancer and negative predictive value and surgical impact in the cN0 neck: results from ACRIN 6685. J Clin Oncol. 2019;37(20):1704-1712.
13.
RobbinsKTClaymanGLevinePA, et al; American Head and Neck Society; American Academy of Otolaryngology–Head and Neck Surgery. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology–Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. 2002;128(7):751-758.
14.
YoudenWJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32-35.
CivantosFJGomezCDuqueC, et al. Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry. Head Neck. 2003;25(1):1-9.
17.
SanliYZukotynskiKMittraE, et al. Update 2018: 18F-FDG PET/CT and PET/MRI in head and neck cancer. Clin Nucl Med. 2018;43(12):e439-e452.
18.
NairSMohanSNilakantanAGuptaAMalikAGuptaA. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India. World J Nucl Med. 2015;14(1):19-24.
19.
ChauhanAKulshresthaPKapoorS, et al. Comparison of PET/CT with conventional imaging modalities (USG, CECT) in evaluation of N0 neck in head and neck squamous cell carcinoma. Med J Armed Forces India. 2012;68(4):322-327.
20.
CarlsonERSchaefferkoetterJTownsendDMcCoyJMCampbellPDJrLongM. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes. J Oral Maxillofac Surg. 2013;71(1):162-177.
21.
LeeSHHuhSHJinSMRhoYSYoonDYParkCH. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2012;147(4):692-698.
22.
OzerENaiboğluBMeachamRRyooCAgrawalASchullerDE. The value of PET/CT to assess clinically negative necks. Eur Arch Otorhinolaryngol. 2012;269(11):2411-2414.
23.
KrabbeCABalinkHRoodenburgJLDolJde VisscherJG. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx. Int J Oral Maxillofac Surg. 2011;40(11):1263-1270.
24.
StoeckliSJHaerleSKStrobelKHaileSRHanyTFSchuknechtB. Initial staging of the neck in head and neck squamous cell carcinoma: a comparison of CT, PET/CT, and ultrasound-guided fine-needle aspiration cytology. Head Neck. 2012;34(4):469-476.
25.
RichardCPrevotNTimoshenkoAP, et al. Preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: does it really improve initial N staging?Acta Otolaryngol. 2010;130(12):1421-1424.
26.
TauzinMRabalaisAHaganJLWoodCGFerrisRLWalvekarRR. PET-CT staging of the neck in cancers of the oropharynx: patterns of regional and retropharyngeal nodal metastasis. Laryngoscope. 2010;120(suppl 4):S186.
27.
HaerleSKStrobelKAhmadNSoltermannASchmidDTStoeckliSJ. Contrast-enhanced 18F-FDG-PET/CT for the assessment of necrotic lymph node metastases. Head Neck. 2011;33(3):324-329.
28.
IyerNGClarkJRSinghamSZhuJ. Role of pretreatment 18FDG-PET/CT in surgical decision-making for head and neck cancers. Head Neck. 2010;32(9):1202-1208.
29.
Al-IbraheemABuckAKrauseBJScheidhauerKSchwaigerM. Clinical applications of FDG PET and PET/CT in head and neck cancer. J Oncol. 2009;2009:208725.
30.
MølstrømJGrønneMGreenABakholdtVSørensenJA. Topographical distribution of sentinel nodes and metastases from T1-T2 oral squamous cell carcinomas. Eur J Cancer. 2019;107:86-92. doi:10.1016/j.ejca.2018.10.021
31.
XingYZhangJLinH, et al. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma. Cancer. 2016;122(4):534-545.
32.
ParkHSChungEJParkMW, et al. Usefulness of radiologic examinations for diagnosing level VI lymph node metastasis in patients with laryngohypopharyngeal carcinoma. Eur Arch Otorhinolaryngol. 2016;273(11):3959-3964.
33.
BarzanLSulfaroSAlbertiF, et al. Gamma probe accuracy in detecting the sentinel lymph node in clinically N0 squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 2002;111(9):794-798.
WelzSZipsD. FDG-PET/CT for exclusion of cervical lymph node metastases in clinically N0 head and neck tumors [in German]. Strahlenther Onkol. 2020;196(2):200-201.
36.
HuKSMouradWFGamezM, et al. Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization. Head Neck. 2017;39(8):1647-1654.
37.
PaleriVUrbanoTGMehannaH, et al. Management of neck metastases in head and neck cancer: United Kingdom national multidisciplinary guidelines. J Laryngol Otol. 2016;130(suppl 2):S161-S169.
38.
MehannaHKongAAhmedSK. Recurrent head and neck cancer: United Kingdom national multidisciplinary guidelines. J Laryngol Otol. 2016;130(suppl 2):S181-S190.
39.
LiaoLJHsuWLWangCTLoWCLaiMS. Analysis of sentinel node biopsy combined with other diagnostic tools in staging cN0 head and neck cancer: a diagnostic meta-analysis. Head Neck. 2016;38(4):628-634.
40.
LiaoLJLoWCHsuWLWangCTLaiMS. Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck—a meta-analysis comparing different imaging modalities. BMC Cancer. 2012;12:236.
41.
BullockMJBeitlerJJCarlsonDL, et al. Data set for the reporting of nodal excisions and neck dissection specimens for head and neck tumors: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting. Arch Pathol Lab Med. 2019;143(4):452-462.
42.
WenzelSSagowskiCKehrlWMetternichFU. The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol. 2004;261(5):270-275.
43.
MiuraKHirakawaHUemuraH, et al. Sentinel node biopsy for oral cancer: a prospective multicenter phase II trial. Auris Nasus Larynx. 2017;44(3):319-326.
44.
ShahJPAndersenPE. The impact of patterns of nodal metastasis on modifications of neck dissection. Ann Surg Oncol. 1994;1(6):521-532.
45.
SchöderHCarlsonDLKrausDH, et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged CN0 by clinical examination and CT/MRI. J Nucl Med. 2006;47(5):755-762.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
